Development and optomization of quercetin-loaded contact lenses for sustained anti-allergic drug delivery
Planta Medica · 01.03.2026 · 92 (03) · 418
DOI: 10.1055/s-0045-1815453 ↗Kurz gefasst
Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.03.2026. Verfasst von S Lee und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Quercetin is known for its potent anti-inflammatory and anti-allergic properties. [ 1 ] However, its clinical application in ophthalmology has been limited due to challenges in delivery and bioavailability. Thus, this study aimed to develop contact lenses containing naturally derived anti-allergic agents and to optimize condition for therapeutic application. Hydrogel (hilafilcon B), and silicone hydrogel (somofilcon A, delefilcon A) lenses were used as drug delivery platforms. Quercetin solution was prepared in phosphate-buffered saline (pH 7.4), and each lens was immersed in quercetin solution at different concentrations(50 μM, 100 μM, and 200 μM) for 0.5, 1, 2, 4, and 8 hours, followed by drying. Drug release from quercetin-loaded contact lenses was assessed at corneal temperature for a total of 120 hours. Quercetin loading amount and efficiency increased with immersion time regardless of lens material. At lower concentrations, hilafilcon B and delefilcon A showed higher loading efficiency compared to somofilcon A. At 200 μM with 8 hour-immersion, all materials exhibited loading efficiency above 70%. At corneal temperature, hilafilcon B showed a higher cumulative release compared to delefilcon A. However, delefilcon A demonstrated superior release efficiency regardless of temperature. Both hilafilcon B and delefilcon A lenses exhibited cumulative quercetin release above 30 μM at corneal temperature. This study established optimal conditions for anti-allergic contact lenses with quercetin immersion in a 200 μM solution for 1 hour. The lenses demonstrated sustained drug release over 120 hours at corneal temperature without burst initial release, suggesting prolonged therapeutic potential. These findings highlight the quercetin’s potential for further clinical evaluation and optimization of therapeutic applications [ 2 ]. Publication History Article published online: 05 March 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Zitieren
APA
Lee, S., Park, M., & Kim, S. (2026). Development and optomization of quercetin-loaded contact lenses for sustained anti-allergic drug delivery. Planta Medica, 92(03), 418. https://doi.org/10.1055/s-0045-1815453
Vancouver
Lee S, Park M, Kim S. Development and optomization of quercetin-loaded contact lenses for sustained anti-allergic drug delivery. Planta Medica. 2026;92(03):418. doi:10.1055/s-0045-1815453
BibTeX
@article{Lee2026,
author = {Lee, S and Park, M and Kim, S},
title = {Development and optomization of quercetin-loaded contact lenses for sustained anti-allergic drug delivery},
journal = {Planta Medica},
year = {2026},
volume = {92},
number = {03},
pages = {418},
doi = {10.1055/s-0045-1815453}
}
EUVIMED